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Background: The Gq/11-protein signaling mechanism is essential throughout the nervous system, but little is known
about the contribution of the individual G-protein GPCR signaling branches towards nociceptor activation and their
specific role on nociceptor sensitization. We aimed to unravel the contribution of the Gq/11-signaling pathway
towards nociceptor activation via a variety of classical inflammatory mediators signalling via different G-protein
GPCRs and investigated the specific contribution of the individual Gq and G11 G-Proteins in nociceptors.
Findings: Using different transgenic mouse lines, lacking Gαq, Gα11 or both α-subunit of the G-proteins in primary
nociceptive neurons, we analyzed the mechanical- and heat-sensitivity upon application of different GPCR-agonists
that are known to play an important role under inflammatory conditions (e.g. ATP, Glutamate, Serotonin etc.). We
found that the Gq/11-GPCR signaling branch constitutes a primary role in the manifestation of mechanical allodynia
and a minor role in the development of thermal hyperalgesia. Moreover, with respect to the mediators used here,
the Gq-protein is the principle G-protein among the Gq/11-protein family in nociceptive neurons leading to
nociceptor sensitization.
Conclusions: Our results demonstrate that the Gq/11 signaling branch plays a primary role in nociceptor
sensitization upon stimulation with classical GPCR ligands, contributing primarily towards the development of
mechanically allodynia. Moreover, the deletion of the individual G-proteins led to the finding that the Gq-protein
dominates the signalling machinery of the Gq/11 family of G-proteins in nociceptive neurons.Findings
Introduction
G-protein coupled receptors (GPCRs) represent the lar-
gest family of seven transmembrane receptors and down-
stream signaling constitutes one of the most important
signaling pathways to regulate physiological processes.
GPCR family members represent a major primary target
for drug development [1,2] and their signaling is a pre-
dominant focus in the development of novel analgesic
therapeutics [3].
Peripheral sensitization is accompanied by an inflamma-
tory milieu, acting on receptors and channels on the per-
ipheral nerve terminals (reviewed in [4]). Most of these
sensitizers are known to bind to GPCRs of the Gq/11 family,
the Gi/o, Gs and G12/13 family of heterotrimeric G-proteins.
We have recently elucidated the specific significance of
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distribution, and reproduction in any mediumin vivo in the context of physiological pain and patho-
logical states [5]. We found that Gq/11 is involved in
sensitization mechanisms in pathological states and tonic-
ally modulates basal nociception and acute pain [5].
There are four members of the Gq/11-protein family,
namely Gq, G11, G14 and G15/16, which activate Phospho-
lipase C beta isoforms to regulate intracellular calcium.
G15/16 overall show very low levels of expression whereas
G14 has been shown to be expressed at high levels select-
ively in some tissues (e.g. kidney, lung and spleen;
reviewed by [6]), and for the first time Han et al. showed
that G14 is expressed in a subset of DRG neurons [7] but
does not compensate for a loss of Gq/11 [5].
The aim of this study was to investigate the individual
role of the Gq or G11 signaling branch towards acute noci-
ceptive behavior induced by different GPCR ligands spe-
cifically activating Gq/11-coupled GPCRs or GPCRs that
are capable to couple different G-protein classes. This is
the first study addressing the distinct roles of Gq and G11
towards nociceptor sensitization.entral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Summary of behavioral results showing main impact of Gq-mediating sensitization processes
Ligand Receptor G-proteinsubclass
Thermal hyperalgesia – paw withdrawal latency Mechanical allodynia – paw withdrawal response frequency








Bradykinin B Gq/11 −51.5 ± 3.3 (n=8) −37.1 ± 2.5 (n=7) −7.4 ± 11.5* (n=7) −8 ± 2.7* (n=7) 54.1 ± 5.5 27.8 ± 8* 14.4 ± 3.6* 6.7 ± 5.9*
UTP P2Y Gq/11 −44.2 ± 10.4 (n=8) −23.8 ± 7.2 (n=8) −9.7 ± 7.5* (n=7) −9.8 ± 5.1* (n=8) 32.8 ± 3.2 20 ± 8.9 4.8 ± 3.5* 6.7 ± 6.0*
Trypsin PAR Gq/11 −41 ± 5.7 (n=8) −38.3 ± 5 (n=8) −17.7 ± 3.3* (n=8) −14.3 ± 8.1* (n=6) −3.3 ± 3.1 4.2 ± 1.8 0.8 ± 0.8
CGRP CGRP Gq/11, Gs −31,3 ± 6.9 (n=7) −29.2 ± 2.3 (n=8) 21.1 ± 8.7 6.7 ± 2.7
ATP P2Y Gq/11, Gs −48.4 ± 4.6 (n=8) −42.2 ± 6.1 (n=7) −16.7 ± 5.5* (n=8) −12.3 ± 4.3* (n=8) 27.5 ± 2 17.1 ± 6.5 4.8 ± 3.8* 5 ± 2.4*
ET-1 ET Gq/11, Gs, G12/13 −39.5 ± 4 (n=8) −42.3 ± 6.2 (n=7) −21.7 ± 3.2* (n=8) −25.5 ± 3.9* (n=7) 26.7 ± 8.5 26.7 ± 5.7 −0.8 ± 4.4* 4.8 ± 5*
PGE2 EP Gq/11, Gs, Gi/o −26.8 ± 5.6 (n=8) −22.2 ± 8.8 (n=8) −6.6 ± 8 (n=8) −8 ± 5.7 (n=7) 15.6 ± 5.8 7.5 ± 4.8 −0.8 ± 2.9* 4.8 ± 5*
Serotonin 5-HT Gq/11, Gs, Gi/o −41.9 ± 3.9 (n=8) −34.4 ± 4.8 (n=8) −31.4 ± 3.1 (n=8) −24 ± 3.2* (n=7) 29.2 ± 5.9 14.2 ± 5.1* 7.5 ± 2.3* 2.9 ± 2*
Glutamate mGluR1,2 Gq/11, Gi/o −45.1 ± 11.8 (n=9) −8.2 ± 6.5 * (n=8) −11.2 ± 4.5* (n=9) −12.5 ± 6.7* (n=9) 19.3 ± 9.7 30.4 ± 8.7 3.3 ± 6.3 6 ± 4.7
mcPAF PAF Gq/11, Gi/o −49 ± 1.8 (n=7) −38.7 ± 4.8 (n=8) −30.7 ± 5 (n=7) −26.7 ± 8.3 (n=8) 30.5 ± 5.8 36.7 ± 7.4 −1 ± 3.1* 5.8 ± 5.6*
Thrombin PAR Gq/11, Gi/o, G12/13 −27.5 ± 6.2 (n=8) −30.1 ± 5 (n=8) 20 ± 3.3 16.7 ± 8.2
S1P S1P Gq/11, Gi/o, G12/13 −51.6 ± 5.7 (n=8) −50.8 ± 5 (n=8) −32.3 ± 4.5* (n=8) −34.2 ± 7.3* (n=8) 23.3 ± 5 20 ± 7.1 4.2 ± 2.5* 0.8 ± 4.1*
Table displays the mean % change of paw withdrawal latency upon thermal stimulation within 90 min upon GPCR-ligand application to the hindpaw and the delta increase of paw withdrawal frequency upon
mechanical stimulation with 0.4 g von Frey filament within 75 min upon GPCR-ligand application. *p<0.05 ANOVA, post-hoc Fisher’s test and boldface, indicates significant differences towards control mice. n = mice




























































































































Figure 1 (See legend on next page.)
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Figure 1 Behavioral responses to intraplantar GPCR-ligands in control mice (black square symbols), G11
−/− mice (green triangle symbols),
SNS-Gq/11
−/− mice (red circular symbols) and SNS-Gq
−/− mice (blue cross symbols). Magnitude and time course of hyperalgesia to plantar heat
following unilateral intraplantar hindpaw injection of Glutamate (A; n= 9 for control, SNS-Gq
−/− and SNS-Gq/11
−/− mice and n= 8 for G11
−/− mice) S1P
(B; n= 8 for all groups) and Thrombin (C; n= 8 for both groups) and of mechanical allodynia to mechanical von Frey filament stimulation following
unilateral injection of Serotonin (D; n= 8 for control, G11
−/− and SNS-Gq/11
−/− mice and n= 7 for SNS-Gq
−/− mice), mcPAF (E; n= 8 for G11
−/− and
SNS-Gq
−/− mice and n= 7 for control and SNS-Gq/11
−/− mice) Endothelin (F; n= 8 for control and SNS-Gq/11
−/− mice and n= 7 for G11
−/− and
SNS-Gq
−/− mice). * P<0.05 as compared to the control group, † as compared to basal values within a group, ANOVA, post hoc Bonferroni’s test. All data
points represent mean ± SEM.
Wirotanseng et al. Molecular Pain 2013, 9:54 Page 4 of 6
http://www.molecularpain.com/content/9/1/54Methods
All animal use procedures were in accordance with eth-
ical guidelines imposed by the local governing body
(Regierungspräsidium Karlsruhe, Germany). All behav-
ioral measurements were done in awake, unrestrained,
age-matched mice that were more than 3 months old, by
individuals who were blinded to the genotype of the
mice being analyzed. Genotypes were identified by gen-
omic tail DNA PCR (as described earlier [5]). Animals
were kept on a 12-hour light–dark cycle with constant
room temperature and behavioral tests were performed
in an appropriate quiet room between 11 am and 4 pm.
We used the following mice, which have been
described in detail (except SNS-Gαq
−/− mice) before
([5,8]): Homozygous mice deficient for Gα11 (Gα11
−/−)




−/−; referred to as Gα11
−/−
in this manuscript), sensory neuron-specific conditional




−/− mice; referred to as SNS-Gαq/11
−/− in this manu-
script), sensory neuron-specific conditional single deficient
mice for Gαq (SNS-Cre
+;Gαq
fl/fl;Gα11
+/+; referred to as
SNS-Gαq
−/− in this manuscript) and mice carrying the
floxed allele of Gαq (Gαq
fl/fl; referred to as control in this
manuscript).
The following classical algogens and agonists were
injected into the plantar surface of the hindpaw in a total
volume of 20 μl: 5 μg Glutamate (27 nmol), 0.1 μg Bradyki-
nin (94 nmol), 40 μg UTP (83 nmol), 5 μg CGRP (1.3 nmol),
1 μg mcPAF (1.85 nmol), 1 μg S1P (2.64 nmol), 60 μg ATP
(0.1 μmol), 10 μg Serotonin (47 nmol), 50 ng PGE2
(142 nmol), 13U Trypsin, 1U Thrombin. Analysis of latency
of paw withdrawal in response to heat was done, as previ-
ously described in detail ([5]; Plantar test apparatus, Ugo
Basile Inc, Comerio, VA, Italy) and mechanical sensitivity
was tested in the same cohort of animals via manual appli-
cation of von Frey hairs to the plantar surface of the hind
paw, as previously described in detail [5]. Two different
substances were tested per mouse with 1–2 weeks of recov-
ery period between the applications at different hindpaws.
We used 6–8 mice per group, the exact numbers per group
are given in Table 1 and the Figure legend.
All data are presented as mean ± standard error of
the mean (S.E.M.). For multiple comparisons, Analysisof Variance (ANOVA) for random measures was per-
formed followed by post-hoc Bonferroni’s test.
Results
The classical deletion of Gα11 led to a complete abrogation
of Glutamate-induced thermal hyperalgesia (Figure 1A,
Table 1) whereas mechanical hyperalgesia was entirely
preserved (Table 1). We found a minor contribution of
G11 towards Serotonin- induced mechanical hyperalgesia
(Figure 1D, Table 1). Interestingly, thermal and mechan-
ical hyperalgesia elicited by PGE2, Trypsin, Bradykinin,
Endothelin1 (ET1), Sphingosin1 Phosphate (S1P), Platelet-
activating factor (PAF), ATP, Thrombin and CGRP were
completely preserved in G11-deficient mice (Figure 1B,
1C, 1E, 1F, Table 1).
We analyzed the algogen-induced behavior in Gq/11
double deficient mice and found a complete loss of ther-
mal hyperalgesia triggered by PGE2, Bradykinin, Glutam-
ate, UTP and ATP, as well as mechanical hyperalgesia
elicit by PGE2, Trypsin, Glutamate, UTP, Serotonin, ET1,
S1P, PAF and ATP (Examples in Figure 1A, 1B, 1D-F,
Table 1). There were minor changes with respect to ther-
mal hyperalgesia upon ET1 and S1P application (Example
in Figure 1B, Table 1), whereas thermal hyperalgesia to-
wards Thrombin, CGRP and Serotonin and mechanical
hyperalgesia towards Thrombin and CGRP was fully pre-
served in Gq/11 double deficient mice (Example in Figure 1C,
Table 1). Interestingly, the deletion of Gq/11 in nociceptors
had a stronger impact on mechanical allodynia than on
thermal hyperalgesia.
Surprisingly, the single deletion of Gq caused the same
behavioral phenotype as the double deletion of Gq and
G11, (examples in Figure 1, Table 1) indicating a predomin-
ant role for Gq- over G11- proteins in nociceptive neurons.Discussion
We found that a particular G-protein pathway can con-
tribute differentially to the action of diverse algogens and
that a particular algogen can employ different G-protein
pathways to elicit thermal hyperalgesia and mechanical
allodynia. The Gq/11 G-protein signaling pathway plays an
important role for nociceptor sensitization and the trans-
duction of GPCR signaling towards the development of
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spect to the mediators tested in this manuscript.
To our surprise Gq has a major impact over G11 medi-
ated nociceptor sensitization. Although Gq and G11 are
nearly ubiquitously expressed in overlapping patterns
[9], including the dorsal root ganglia and spinal cord [7],
it cannot be ruled out that specific, highly localized dif-
ferences may exist between the expression pattern and
subcellular distribution of Gq and G11 in central circuits
mediating hyperalgesia. Previous studies showing no dif-
ference in receptor-coupling with respect to Gq or G11
are performed in vitro [10-13] and thereby might not re-
flect the in vivo situation. It is more likely that different
expression levels as shown for different brain regions
[14-17] or membrane compartmentalization might ac-
count for the observed phenotypes. With respect to the
DRGs it seems that there is a signaling succession for mem-
bers of the Gq/11 family. G15/16 are not expressed, G14, G11
and Gq are expressed, while G14 has no specific role, G11
plays only a minor role for nociceptor sensitization and Gq
is the most prominent G-proteins of this important signal-
ing family. The classical deletion of Gq is known to be lethal
[17], indicating essential requirement for this particular
G-protein and no possible compensation of other G-
proteins from different G-protein classes. Within the
Gq/11 G-protein class, a preferential signaling role of Gq
over G11 signaling has been demonstrated in various
systems [14-16,18-20] and the Gq-protein mediated sig-
naling pathway in DRGs seems to have the major role
over all other possible G-protein pathways which are in-
volved in signal transduction upon receptor activation
after application of ligands. We used the Cre-lox P sys-
tem for conditional deletion such that the gene deletion
only commences prenatally, thereby excluding early de-
velopmental deficits in SNS-Gq−/− mice, but we cannot
rule out compensatory mechanisms of Gq in G11
−/−
mice as it has been suggested earlier [21].
Moreover, we were surprised to see the predominant
contribution of the Gq/11 signaling pathway over Gs or Gi/o
signaling with respect to those substances that are known
to activate GPCRs which can bind different classes of G-
protein, e.g. ATP, ET1, Glutamate, PAF, PGE2, Serotonin,
S1P or Thrombin. Whereas the inhibitory Gi/o proteins
contribute to anti-nociceptive signaling pathway, Gs and
Gq/11 protein signaling mediates pro-nociceptive signaling
(reviewed in [3]). For example PGE2, a crucial mediator for
inflammatory pain couples to Gq/11-, Gi/o- and Gs-GPCRs
but does not elicit thermal hyperalgesia or mechanical allo-
dynia in mice lacking Gq, indicating a major contribution
of the Gq-GPCR signaling pathway. Similarly, ATP or Sero-
tonin, which can bind Gq/11- and Gs-GPCRs, do not lead
to mechanical allodynia in Gq-deficient mice indicating a
dominant role of Gq over the other G-proteins which are
known to couple to the same receptors. On the contrary,thermal hyperalgesia and mechanical allodynia induced by
CGRP (which can activate Gq/11- and Gs- coupled GPCRs)
or Thrombin (which can bind Gq/11- Gi/o- and G12/13-
GPCRs) are fully preserved, indicating that compensatory
mechanisms via other G-proteins are functional.
Interestingly, with respect to thermal hyperalgesia only
ATP-mediated heat hyperalgesia is abrogated in Gq-defi-
cient mice whereas Serotonin-induced heat hyperalgesia is
preserved in these animals. This predominant role of the
Gq-protein in mediating mechanical allodynia over ther-
mal hyperalgesia was also found for Endothelin and to
some extend for S1P. It seems that the Gq/11 signaling path-
way contributes significantly to mechanical allodynia elic-
ited via a broad range of inflammatory mediators herein
tested and that GPCR agonist-induced heat hyperalgesia is
mediated via distinct G-protein GPCRs or other receptors.
Our results constitute a valuable tool to work out
in vivo conditions of established nociceptive sensitizers.
Moreover, this tool can be used for studying the mecha-
nisms of action of new mediators in pain sensitization.
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